Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
96
NCT00544921
Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2005
Completion: Oct 31, 2006
NCT00544934
Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects
Phase: Phase 1/2
Start: Feb 28, 2007
Completion: Oct 31, 2007